Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by <i>NTRK</i> gene fusions“

The Advisory Board was held on December 24, 2021. The molecular genetic research lead specialists and national lead oncologists discussed issues of diagnosis of NTRK gene translocations in patients with non-small cell lung cancer (NSCLC), as well as current opportunities for the treatment of patient...

Description complète

Détails bibliographiques

Auteurs principaux:	E. V. Artamonova, V. V. Breder, L. Yu. Vladimirova, I. A. Demidova, E. N. Imyanitov, К. К. Laktionov, M. P. Matrosova, S. V. Orlov, E. О. Rodionov, D. D. Sakaeva, M. I. Sekacheva, A. V. Smolin, N. V. Fadeeva, M. L. Filipenko
Format:	Artigo
Langue:	Russo
Publié:	Remedium Group LLC 2022-06-01
Collection:	Медицинский совет
Sujets:	<i>ntrk</i> gene fusions larotrectinib ngs (next generation sequencing) trk inhibitors non-small cell lung cancer
Accès en ligne:	https://www.med-sovet.pro/jour/article/view/6916
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!